Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
Speakers Jehan Marino, PharmD, BCPP and Mark Tacelosky, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)